SAB Biotherapeutics Inc
Biotechnology
Healthcare
SABS
9.29 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
2.47
52 week high
4.65
high
2.49
52 week low
0.00
previous Close
2.48
P/E ratio
-2
market cap
23.11 M
div yield
0
net incoming
-10.11 M
-94.62 %
net profit margin
-1011427000.00 %
0.00 %
operating incoming
-9.73 M
9.65 %
net change in cash
2.94 M
190.11 %
cash on hand
3.69 M
-34.54 %
cost of revenue
822 K
0.00 %
top